Dopamine-loaded poly(d,l-lactic-co-glycolic acid) microspheres: New strategy for encapsulating small hydrophilic drugs with high efficiency

Biotechnology Progress

Volumn 30, Issue 1, 2014, Pages 215-223

  Shin, Mikyung ^a   Kim, Hong Kee ^b   Lee, Haeshin ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b SK Chemicals   (South Korea)

Author keywords

Dopamine; Emulsifying polymers; Encapsulation efficiency; Intermolecular interactions; Poly(lactic co glycolic acid) microspheres

Indexed keywords

DOPAMINE; DRUG-LOADING EFFICIENCY; ENCAPSULATION EFFICIENCY; INTERMOLECULAR INTERACTIONS; PARKINSON'S DISEASE; POLY(D , L-LACTIC-CO-GLYCOLIC ACID); POLY(D ,L LACTIC CO GLYCOLIC ACID) (PLGA); POLY(LACTICCO-GLYCOLIC ACID) MICROSPHERE;

AMINES; COPOLYMERS; EMULSIFICATION; ENCAPSULATION; MICROSPHERES; NEUROPHYSIOLOGY; POLYMERS; POLYVINYL ALCOHOLS;

HYDROPHILICITY;

DOPAMINE; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG FORMULATION; EMULSIFYING POLYMERS; EMULSION; ENCAPSULATION EFFICIENCY; INTERMOLECULAR INTERACTIONS; METHODOLOGY; POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES; VISCOSITY;

DOPAMINE; EMULSIFYING POLYMERS; ENCAPSULATION EFFICIENCY; INTERMOLECULAR INTERACTIONS; POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES;

DOPAMINE; DRUG COMPOUNDING; EMULSIONS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; VISCOSITY;

EID: 84893751044     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1835     Document Type: Article

References (33)

1. Singh N, Pillay V, Choonara YE. Advances in the treatment of Parkinson's disease. Prog Neurobiol. 2007;81:29-44.
2. Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, Gust R, Goepferich A, Benoit JP, Siepmann J. Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int J Pharm. 2006;314:127-136.
3. Mcrae-Degueurce A, Hjorth S, Dillon DL, Mason DW, Tice TR. Implantable microencapsulated dopamine (DA): a new approach for slow-release DA delivery into brain tissue. Neurosci Lett. 1988;92:303-309.
4. Trapani A, Giglio ED, Cafagna D, Denora N, Agrimi G, Cassano T, Gaetani S, Cuomo V, Trapani G. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int J Pharm. 2011;419:296-307.
5. Ma X, Zhao Y, Liang X. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc Chem Res. 2011;44:1114-1122.
6. Foley P, Gerlach M, Double KL, Riederer P. Dopamine receptor agonists in the therapy of Parkinson's disease. J Neural Transm. 2004;111:1375-1446.
7. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 1991;8:713-720.
8. Kim HK, Park TG. Microencapsulation of dissociable human growth hormone aggregates within poly(D, L-lactic-co-glycolic acid) microparticles for sustained release. Int J Pharm. 2001;229:107-116.
9. Bezemer JM, Radersma R, Grijpma DW, Dijkstra PJ, Blitterswijk CA, Feijen J. Microspheres for protein delivery prepared from amphiphilic multiblock copolymers 1. Influence of preparation techniques on particle characteristics and protein delivery. J Controlled Release. 2000;67:233-248.
10. Bezemer JM, Radersma R, Grijpma DW, Dijkstra PJ, Blitterswijk CA, Feijen J. Microspheres for protein delivery prepared from amphiphilic multiblock copolymers 2. Modulation of release rate. J Controlled Release. 2000;67:249-260.
11. Vrignaud S, Benoit J. Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32:8593-8604.
12. Ruan G, Feng S. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials. 2003;24:5037-5044.
13. DeFail AJ, Edington HD, Matthews S, Lee WC, Marra KG. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds. J Biomed Mater Res A. 2006;79A:954-962.
14. Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004;27:1-12.
15. Ogawa Y, Yamamoto M, Okada H, Yashiki T, Shimamoto T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem Pharm Bull. 1988;36:1095-1103.
16. Mehta RC, Thanoo BC, DeLuca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly(d, l-lactide-co-glycolide). J Controlled Release. 1996;41:249-257.
17. Sinisterra RD, Shastri VP, Najjar R, Langer R. Encapsulation and release of rhodium(II) citrate and its association complex with hydroxypropyl-ß-cyclodextrin from biodegradable polymer microspheres. J Pharm Sci. 1999;88:574-576.
18. Li X, Deng X, Yuan M, Xiong C, Huang Z, Zhang Y, Jia W. Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. Int J Pharm. 1999;178:245-255.
19. Kang SM, Hwang NS, Yeom J, Park SY, Messersmith PB, Choi IS, Langer R, Anderson DG, Lee H. One-step multipurpose surface functionalization by adhesive catecholamine. Adv Funct Mater. 2012;22:2949-2955.
20. Waite JH, Benedict CV. Assay of dihydroxyphenylalanine (Dopa) in invertebrate structural proteins. Method Enzymol. 1984;107:397-413.
21. Takai C, Hotta T, Shiozaki S, Matsumoto S, Fukui T. Effect of inorganic salt on formation of porous PLGA microspheres. Chem Lett. 2011;40:638-639.
22. Bae SE, Son JS, Park K, Han DK. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J Controlled Release. 2009;133:37-43.
23. Kim HK, Chung HJ, Park TG. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. J Controlled Release. 2006;112:167-174.
24. Yang Y, Chia H, Chung T. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J Controlled Release. 2000;69:81-96.
25. Ryu JH, Lee Y, Kong WH, Kim TG, Park TG, Lee H. Catechol-functionalized chitosan/pluronic hydrogels for tissue adhesives and hemostatic materials. Biomacromolecules. 2011;12:2653-2659.
26. Lee H, Dellatore SM, Miller WM, Messersmith PB. Science. 2007;318:426-430.
27. Senthilkumar KS, Saravanan KS, Chandra G, Sindhu KM, Jayakrishnan A, Mohanakumar KP. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism. Behav Brain Res. 2007;184:11-18.
28. Miya M, Iwamoto R, Mima S. FT-IR study of intermolecular interactions in polymer blends. J Polym Sci Part B: Polym Phys. 1984;22:1149-1151.
29. Hong S, Na YS, Choi S, Song IT, Kim WY, Lee H. Non-covalent self-assembly and covalent polymerization co-contribute to polydopamine formation. Adv Funct Mater. 2012;2:4711-4717.
30. Nikolic GM, Premović PI, Nikolić RS. Spectrophotometric study of catechol oxidation by aerial O2 in alkaline aqueous solutions containing Mg(II) ions. Spectrosc Lett. 1998;31:327-333.
31. Karatas A, Sonakin O, Kilicarslan M, Baykara T. Poly (e-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics. J Microencapsul. 2009;26:63-74.
32. Yang Y, Chung T, Bai X, Chan W. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci. 2000;55:2223-2236.
33. Xu Q, Crossley A, Czernuszka J. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres. J Pharm Sci. 2009;98:2377-2389.